Showing 6-10 of 168 news & articles:
Joseph Zabinski Of OM1: How AI Is Disrupting Our Industry, and What We Can Do About It

Authority Magazine October 6, 2024 Read the full article >> Invest in training and upskilling — Ensuring teams are equipped with the necessary skillset to work alongside AI is critical for success and responsible use of the technology. This includes comprehensive training on the foundation of AI, implementing AI, and special use cases of AI in[…]

AI and Real-World Evidence: Transforming Pharmaceutical Research and Market Access

Market Access Today October 5, 2024 Read the full article >> Key Questions Answered What are the primary areas of specialization for an insights-driven technology and data company? How does such a company (an insights-driven technology and data company) utilize AI in its operations? In what ways does this impact patient outcomes and research advancement?[…]

Driving Point-of-care Decisions With RWE

Applied Clinical Trails October 1, 2024 Watch the full video >> In this video interview with ACT editor Andy Studna, Rich Gliklich, founder of OM1 highlights personalized medicine and predicting disease outcomes. ACT: Looking forward, how will real-world evidence (RWE) drive point-of-care decisions? Gliklich: I love this question because one of the reasons we started OM1[…]

The Potential of AI in Data Collection

Applied Clinical Trials September 30, 2024 Watch the full video >> In this video interview with ACT editor Andy Studna, Rich Gliklich, founder of OM1 discusses automating data collection and organizing unstructured data. ACT: Is there any potential for the use of artificial intelligence (AI) in the data collection space? Gliklich: I love that question because[…]